Institutional investors purchased a net $550.3 thousand shares of VCEL during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 45.49% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARCHON CAPITAL MANAGEMENT LLC Bought 1.3 Million shares of Vericel Corp
CONSONANCE CAPITAL MANAGEMENT LP Bought 458.3 Thousand shares of Vericel Corp
PERKINS CAPITAL MANAGEMENT, INC. Bought 305.0 Thousand shares of Vericel Corp